These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7520677)
41. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer. Liang DC Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625 [TBL] [Abstract][Full Text] [Related]
42. Colony-stimulating factors after the treatment of pediatric malignant diseases. Schuler D Pediatr Hematol Oncol; 1997; 14(1):iii-v. PubMed ID: 9021806 [No Abstract] [Full Text] [Related]
48. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939 [TBL] [Abstract][Full Text] [Related]
49. Filgrastim and antibiotics treatment reduces neutropenia severity in solid cancer patients. Hassan BA; Yusoff ZB; Othman SB Asian Pac J Cancer Prev; 2009; 10(4):641-4. PubMed ID: 19827886 [TBL] [Abstract][Full Text] [Related]
50. Disappointments in treating acute leukemia in the elderly. Hamblin TJ N Engl J Med; 1995 Jun; 332(25):1712-3. PubMed ID: 7539110 [No Abstract] [Full Text] [Related]
51. [Small cell lung cancer: value of G-CSF]. Trillet V Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284 [No Abstract] [Full Text] [Related]
52. Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects. Vreugdenhil G; Schattenberg A; Dompeling EC; Swaak AJ; De Witte T Am J Med; 1993 Feb; 94(2):229-31. PubMed ID: 7679247 [No Abstract] [Full Text] [Related]
53. [Use of G-CSF in chemotherapy of urogenital cancers]. Droz JP; Théodore C Pathol Biol (Paris); 1993 Jan; 41(1):48-9. PubMed ID: 7686286 [No Abstract] [Full Text] [Related]
54. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D; Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664 [TBL] [Abstract][Full Text] [Related]
55. Hematopoietic growth factors as an adjunct for neutropenic patients in the ICU: still a controversial issue. Serke S Intensive Care Med; 1999 Sep; 25(9):901-2. PubMed ID: 10501743 [No Abstract] [Full Text] [Related]
56. Prevention and therapy of neutropenia in elderly patients. Rosti G; Kopf B; Cariello A; Monti M; Dazzi C; Papiani G; Giovanis P; De Giorgi U; Marangolo M Crit Rev Oncol Hematol; 2003 Jun; 46(3):247-53. PubMed ID: 12791424 [TBL] [Abstract][Full Text] [Related]
57. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia]. Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397 [No Abstract] [Full Text] [Related]
59. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Bohlius J; Reiser M; Schwarzer G; Engert A Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474 [TBL] [Abstract][Full Text] [Related]
60. [The use of hematopoietic growth factors G-CSF/GM-CSF in the treatment of neutropenia in children with acute lymphoblastic leukemia and non-Hodgkin's lymphomas]. Nowak K; Pekacka K; Trelińska J; Stolarska M; Bodalski J Wiad Lek; 1998; 51 Suppl 4():237-42. PubMed ID: 10731975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]